Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials01:16

Clinical Trials

9.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
9.9K
Data Collection by Experiments01:13

Data Collection by Experiments

26.4K
Data collection is a systematic method of obtaining, observing, measuring, and analyzing accurate information. An experimental study is a standard method of data collection that involves the manipulation of the samples by applying some form of treatment prior to data collection. It refers to manipulating one variable to determine its changes on another variable. The sample subjected to treatment is known as “experimental units.”
An example of the experimental method is a public...
26.4K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

223
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
223
Data Validation01:03

Data Validation

6.0K
Data validation is an essential part of a comprehensive assessment. Validation is confirming or verifying and opening the door to gathering more assessment data as it clarifies vague or unclear data. The process of checking and verifying the collected information is called data validation. The primary purpose of data validation is to ensure data is as free from error, bias, and misinterpretation as possible.
Nursing assessment guides are generally based on holistic models rather than medical...
6.0K
Data Validation01:15

Data Validation

371
Method validation is a crucial process in analytical chemistry designed to confirm that a given method consistently produces reliable and high-quality results. This process is essential when a method is applied to different sample matrices or when procedural modifications are made, ensuring that the results meet acceptable standards across various applications.
Key parameters for method validation include:
371
Clinical Trials: Overview01:11

Clinical Trials: Overview

4.1K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clustering of Social Determinants of Health and Their Association With Adverse Cardiovascular Outcomes in Atrial Fibrillation.

Journal of the American Heart Association·2026
Same author

An Evaluation of Pretrained Generative Models for Augmenting Small Health Data: Comparative Modeling Study.

Journal of medical Internet research·2026
Same author

Beyond motor: a systematic review of multisensory integration deficits in Parkinson's disease.

Journal of neural transmission (Vienna, Austria : 1996)·2026
Same author

Direct C-H difluoromethylation of heteroaromatic compounds: emerging methods and developments through 2025.

RSC advances·2026
Same author

Transfer Learning and Machine Learning for Training Five-Year Survival Prognostic Models in Early Breast Cancer: Development and Validation Study.

Journal of medical Internet research·2026
Same author

The association between serum trace elements and iron deficiency anemia in children and adolescents: a systematic review and meta-analysis.

Hematology (Amsterdam, Netherlands)·2026

Related Experiment Video

Updated: Nov 9, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.8K

Can synthetic data be a proxy for real clinical trial data? A validation study.

Zahra Azizi1, Chaoyi Zheng2, Lucy Mosquera2

  • 1Center for Outcomes Research and Evaluation, Faculty of Medicine, McGill University, Montreal, Québec, Canada.

BMJ Open
|April 17, 2021
PubMed
Summary
This summary is machine-generated.

Synthetic data accurately replicated clinical trial findings, showing promise for broader data sharing. This approach addresses privacy concerns and enhances research accessibility.

Keywords:
epidemiologyhealth informaticsinformation managementinformation technologystatistics & research methods

More Related Videos

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.0K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.3K

Related Experiment Videos

Last Updated: Nov 9, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.8K
In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.0K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.3K

Area of Science:

  • Clinical trial data analysis
  • Machine learning applications in healthcare
  • Synthetic data generation

Background:

  • Increasing demand for secondary analysis of clinical trial data.
  • Privacy requirements pose challenges to data availability.
  • Synthetic data offers a potential solution to enhance data accessibility.

Purpose of the Study:

  • To replicate a secondary analysis of a stage III colon cancer trial using synthetic data.
  • To evaluate the utility of machine learning-generated synthetic data as a proxy for real clinical trial data.

Main Methods:

  • Replicated published analyses on a real colon cancer trial dataset using synthetic data.
  • Employed information theoretic metrics to compare univariate distributions.
  • Utilized percentage confidence interval (CI) overlap to assess bivariate and multivariate Cox model similarities.

Main Results:

  • Analysis results from synthetic and real datasets showed high concordance.
  • Univariate distributions differed by less than 1% using information theoretic metrics.
  • Bivariate relationships exhibited over 50% CI overlap, with key survival conclusions replicated.

Conclusions:

  • Synthetic data serves as a viable proxy for real clinical trial datasets.
  • High concordance supports the use of synthetic data for secondary analyses.
  • Synthetic data can facilitate broader data sharing while maintaining privacy.